UNITY is developing a new class of therapeutics to slow, halt or reverse diseases of aging. UNITY’s current focus is on creating medicines to selectively eliminate or modulate senescent cells and thereby provide transformative benefit in age-related ophthalmologic and neurologic diseases. 

Biotechnology

UNITY Biotechnology

Anirvan Ghosh

Noema Pharma

Federico Grossi

Gilmore O’Neill

Alicia Tozier

Sara Huang

Mike Sapieha

Alexander Nguyen

Qifeng Xue

David Buttaro

Przemyslaw (Mike) Sapieha

Lynne Sullivan

Leadership Team

Clinical and Research Team

Teams at UNITY Biotechnology

Leadership Team

Clinical and Research Team